response to norepinephrine / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / Endogenous sterols / Synthesis of bile acids and bile salts / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / Recycling of bile acids and salts / negative regulation of triglyceride biosynthetic process / regulation of carbohydrate metabolic process / regulation of lipid storage / regulation of urea metabolic process ...response to norepinephrine / Synthesis of bile acids and bile salts via 27-hydroxycholesterol / Endogenous sterols / Synthesis of bile acids and bile salts / Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol / Recycling of bile acids and salts / negative regulation of triglyceride biosynthetic process / regulation of carbohydrate metabolic process / regulation of lipid storage / regulation of urea metabolic process / chenodeoxycholic acid binding / positive regulation of phosphatidic acid biosynthetic process / positive regulation of glutamate metabolic process / positive regulation of ammonia assimilation cycle / regulation of low-density lipoprotein particle clearance / intracellular triglyceride homeostasis / cellular response to bile acid / SUMOylation of intracellular receptors / negative regulation of very-low-density lipoprotein particle remodeling / Nuclear Receptor transcription pathway / negative regulation of interleukin-1 production / negative regulation of collagen biosynthetic process / leukocyte migration involved in inflammatory response / regulation of insulin secretion involved in cellular response to glucose stimulus / negative regulation of monocyte chemotactic protein-1 production / toll-like receptor 9 signaling pathway / nuclear receptor-mediated bile acid signaling pathway / bile acid nuclear receptor activity / bile acid metabolic process / response to cholesterol / cell-cell junction assembly / bile acid binding / triglyceride homeostasis / digestive tract development / cellular response to fatty acid / negative regulation of interleukin-2 production / bile acid and bile salt transport / positive regulation of interleukin-17 production / intracellular glucose homeostasis / negative regulation of interleukin-6 production / negative regulation of type II interferon production / positive regulation of insulin secretion involved in cellular response to glucose stimulus / negative regulation of tumor necrosis factor production / negative regulation of tumor necrosis factor-mediated signaling pathway / fatty acid homeostasis / positive regulation of insulin receptor signaling pathway / nuclear retinoid X receptor binding / response to glucose / intracellular receptor signaling pathway / negative regulation of canonical NF-kappaB signal transduction / positive regulation of adipose tissue development / Notch signaling pathway / peptide binding / cholesterol homeostasis / transcription coregulator binding / RNA polymerase II transcription regulatory region sequence-specific DNA binding / response to nutrient levels / euchromatin / : / negative regulation of inflammatory response / RNA polymerase II transcription regulator complex / response to estrogen / nuclear receptor activity / glucose homeostasis / cellular response to xenobiotic stimulus / cellular response to lipopolysaccharide / DNA-binding transcription activator activity, RNA polymerase II-specific / response to lipopolysaccharide / sequence-specific DNA binding / response to ethanol / transcription by RNA polymerase II / cell differentiation / DNA-binding transcription factor activity, RNA polymerase II-specific / receptor complex / defense response to bacterium / RNA polymerase II cis-regulatory region sequence-specific DNA binding / response to xenobiotic stimulus / DNA-binding transcription factor activity / innate immune response / positive regulation of gene expression / regulation of transcription by RNA polymerase II / protein-containing complex binding / negative regulation of apoptotic process / positive regulation of DNA-templated transcription / negative regulation of transcription by RNA polymerase II / positive regulation of transcription by RNA polymerase II / DNA binding / zinc ion binding / nucleus Similarity search - Function
A: Bile Acid Receptor B: Bile Acid Receptor C: dodecamer peptide fragment of RPGR-interacting protein 1 D: dodecamer peptide fragment of RPGR-interacting protein 1 E: dodecamer peptide fragment of RPGR-interacting protein 1 hetero molecules
B: Bile Acid Receptor D: dodecamer peptide fragment of RPGR-interacting protein 1 E: dodecamer peptide fragment of RPGR-interacting protein 1 hetero molecules
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi